Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
Adrian Castro
Mrs D.I.
60 y/o female Presents to ED on Monday 26/3 HPI
Sudden onset SOB since Sunday, worse on exertion Coughing + green phlegm Audible wheeze, present since Sunday Chest pain around diaphragm with cough/inspiration Painful calves for past 2 weeks denies fever
Differentials?
Differentials
Asthma exacerbation COPD exacerbation Pulmonary Embolism Pneumonia
ED - Initial Management?
Initial Management
Nebulize
Salbutamol Ipravent
Further History?
PMHx
IDDM HTN Cholesterol Osteoarthritis GORD Asthma Emphysema
PMHx
OSA 5 year Hx of orthopnoea sleeps on recliner Mar 2009 - Left renal cancer Aug 2010 right DVT Nov 2011 - Pancreatitis 2nd to gallstones
Medications
Clexane 100mg bd Hydromorphone Jurnista & dilaudid Panadol osteo Pantoprazole Lipitor Atacand Plus
Medications
Ventolin Spiriva Seretide Novarapid Lantus
Social
Ex smoker
Quit 4 years ago Hx of 50/day/30+ years
Lives with husband and son Not completely independent with all ADLs
Needs help showering
Investigations?
Investigations
FBC: unremarkable EUC: high creatinine 111 (0.7-1.4) LFT: high GGT 122 (10-55) ABG:
pH - 7.40 PO2 - 78 PCO2 - 46 HCO3 - 28
Investigations
D-Dimer
used when CSSs show low to moderate risk *not a diagnostic test but a test for exclusion Negative value indicates low likelihood of venous thromboembolism Positive value does not rule out DVT/PE because there are many other causes of thrombosis
i.e. Liver disease, infection, malignancy, trauma, pregnancy
Investigations
CTPA
Appearance suggestive of several small pulmonary emboli in relation to 2nd/3rd order vessels involving: - L upper and lower lobes - R middle lobe
Treatment
Anticoagulation
Clexane
dose increased to 120mg bd on haematologist recommendation Check therapeutic level with Anti factor Xa level
Warfarin
Peak effect doesnt occur until 36-72hrs after Check therapeutic level with INR (2-3)
Treatment
Thrombolysis
Indicated when patient shows signs of haemodynamic instability Suggested for non-hypotensive, high-risk patients who have a low risk of bleeding
*PE severity vs prognosis vs risk of bleeding to decide whether to commence thrombolytic therapy
Risk Factors
Virchows Triad Hereditary
Protein C/S, Plasmin, Anti-thrombin III, fibrinogen
Recent Surgery Trauma Immobilization Pregnancy Infection Malignancy OCP and HRT
Thank you :)